Popular Articles

Dems' Health Care Reform Plans Would Include Abortion Coverage, Washington Times Opinion Piece States
As lawmakers work to pass health reform legislation, "few are talking about" the "essential question" of whether "health reform will force taxpayers to pay for abortions for the first time in 30 years," Family Research Council President Tony Perkins writes in a Washington Times opinion piece. According to Perkins, "the short answer is yes" because there is no "explicit provision" in any Democratic health plan that would "[p]revent taxpayer funding of abortions as part of the health care benefit Congress is considering"; avert "delays in health care services that result in the death of the patient waiting for care"; or allow health care providers "to refuse to participate in health care-related action that violates their conscience." Perkins continues that the House"s reform proposal would provide federal coverage for ""family planning," the well-worn buzz word that includes abortion unless specified to the contrary." He adds that "it would be naive to assume, unless there is an explicit prohibition in the bill, that [HHS] Secretary Kathleen Sebelius will not use her discretion to fund abortions with taxpayers" money." Perkins also writes that the Democratic reform plans, "in short, ... attempt to be silent on the key question of whether or not to allow the U.S. government to fund abortions with taxpayers" money," and also give the HHS secretary "the power to allow taxpayer-funded abortions."He writes, "The Family Research Council"s answer is clear: There must be a permanent prohibition on taxpayer-funded abortions," as well as "provision to allow a right of conscience for doctors and nurses and other health care providers" to refuse to participate in treatments they oppose. He adds that "there can be no system of denial or delay or rationing of care." Perkins concludes, "Euthanasia by any other name is a poison pill in the health reform debate" (Perkins, Washington Times, 7/5)

Anti Nausea Drug Deemed Safe For Fetuses: Ben-Gurion U.
Metoclopramide, a drug approved in the U.S. for nausea, vomiting and heartburn poses no significant risks for the fetus according to a large cohort study published in the June 11 issue of the prestigious New England Journal of Medicine, "The Safety of Metoclopramide Use in the First Trimester of Pregnancy" (N Engl J Med 2009;360:24 June 11, 2009).
News of the day
Secretary Sebelius Releases New Success Story Report: Community-Based Prevention Program In Nebraska Helps Prevent Heart Disease And Stroke
HHS Secretary Kathleen Sebelius today released the second in a series of health care success story reports that document innovative programs and initiatives that can serve as models for a reformed American health care system. Today"s report highlights the Nebraska WISEWOMAN program. WISEWOMAN is a community intervention program funded by the Centers for Disease Control and Prevention that helps prevent heart disease and stroke by providing screenings and counseling for low-income women. The report is available at http://www.healthreform.gov.
Health Insurance

The HUGO Journal Joins Springer's Biomedical Sciences Portfolio

Starting in October 2009, Springer will publish The HUGO Journal in cooperation with the Human Genome Organisation (HUGO). Formerly published at Springer as Genomic Medicine, The HUGO Journal has a new design, new features and a new editorial team. Members of HUGO will receive free access to the journal online and be able to purchase print subscriptions at discounted rates. The HUGO Journalwill focus on discoveries arising from the basic, clinical and population explorations of the human genome and genomes of organisms relevant to human health. The journal will publish primary research papers of the highest quality as well as in-depth review articles on important topics pertaining to genomic medicine, human genetics, computational genomics and genomic technologies. The HUGO Journal will also publish key consensus reports and policy guidelines from the HUGO Council and its subcommittees. Several new sections featuring the description and utility of genomic databases as well as special reports on innovation and technology advances will be offered to foster the exchange of information relevant to genomic scientists. "We are delighted to work with Springer to publish The HUGO Journal. In line with our new direction to focus on enhancing genomic capabilities, The HUGO Journal will definitely be an important instrument to promote knowledge, excitement and networking," said Professor Edison Liu, President of HUGO and Executive Director of the Genome Institute of Singapore. Peter Butler, Editorial Director, Biomedical Unit at Springer, said, "We are very pleased to be partnering with such a prestigious society. Working together with the Human Genome Organisation, we look forward to supporting the advance of genomics research. The Human Genome Organisation, an international organisation established in 1988, encourages collaboration among genome scientists around the world. Now that the human genome has been sequenced, the organisation is seeking the biological meaning of its information content and to this end, is focusing on the medical implications of genomic knowledge. HUGO also works to improve the genomic capabilities in the emerging countries of the world. Springer is a leading global scientific publisher of books and journals, delivering quality content through innovative information products and services. It publishes close to 500 academic and professional society journals. Springer is part of the publishing group Springer Science+Business Media. In the science, technology and medicine (STM) sector, the group publishes around 2,000 journals and more than 6,500 new books a year, as well as the largest STM eBook Collection worldwide. Springer has operations in about 20 countries in Europe, the USA, and Asia, and more than 5,000 employees. The HUGO Journal ISSN: 1877-6558 (print version), ISSN: 1877-6566 (electronic version) Joan Robinson Springer


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):